0000000000394570

AUTHOR

Alexander A. Navarini

showing 8 related works from this author

Pruritic and antipruritic colors: An exploratory pilot study.

2020

Itch is the commonest skin-related symptom and can be influenced by visual cues as exemplified by the phenomenon of "contagious itch." Colors are visual cues able to modify somatosensory inputs. We explored the relationship of colors and itch and the impact of color viewing on itch intensity. In this cross-sectional study, patients suffering from itch with a mean intensity of ≥2 on a Numerical Rating Scale during the last 7 days were evaluated. The study consisted of a questionnaire-based part using The Manchester Color Wheel and the ItchyQoL, followed by an interventional part. All 72 itch patients were able to match their itchy sensation with a color: In 68 patients (94.4%) this "pruritic…

medicine.medical_specialtybusiness.industryPruritusColorPilot ProjectsDermatologyGeneral MedicineAntipruriticsDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineCross-Sectional Studies030220 oncology & carcinogenesisSensationQuality of LifeMedicineHumansColor wheelbusinessAntipruriticmedicine.drugDermatologic therapyREFERENCES
researchProduct

Pitfall prayer marks: Recognition and appropriate treatment: A case report and review of literature.

2019

Prayer marks are asymptomatic callosities resulting from repeated, extended pressure, and friction exerted on bony prominences when praying on hard ground. A 41-year-old woman with ulcerative colitis treated with infliximab was referred to our clinic due to skin changes on her feet that were suspected to be drug eruptions. The patient presented several asymptomatic, hyperpigmented, and hyperkeratotic plaques over the lateral malleoli suggesting that the lesions had a mechanical cause. Further exploration revealed that the patient, a practicing Muslim, prays in a sitting position called "Julus" several times a day. After color marking, the lesions over the lateral feet left a precise imprint…

Adultmedicine.medical_specialtymedia_common.quotation_subjectDermatologyIslam030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineHyperpigmentationMedicineHumansmedia_commonSkinCallositybusiness.industryFootGeneral surgeryGeneral MedicinehumanitiesPrayerInfliximab030220 oncology & carcinogenesisColitis UlcerativeFemaleHyperkeratotic plaquesDrug EruptionsbusinessSkin lesionDermatologic therapyREFERENCES
researchProduct

Safety of the current drug treatments for vitiligo

2020

Introduction: Vitiligo is an acquired depigmenting skin disorder adversely affecting the patient's quality of life. Despite the presence of several treatment modalities, ranging from medical to physical to surgical options, none is curative. Each modality has its own drawbacks and side effects. Thus, the treatment modality needs to be tailored for each individual patient taking into consideration the disease characteristics and also its efficacy and safety to obtain a favorable risk-benefit ratio.Areas covered: This review highlights the different treatment modalities utilized in vitiligo up until 4 November 2019 along with their adverse effects and contraindications, if any.Expert opinion:…

Drugmedicine.medical_specialtymedia_common.quotation_subjectVitiligoVitiligo030204 cardiovascular system & hematologyAdministration Cutaneous03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Adrenal Cortex HormonesmedicineHumansEffective treatmentPharmacology (medical)Intensive care medicineAdverse effectmedia_commonBiological ProductsModality (human–computer interaction)business.industryGeneral Medicinemedicine.diseaseTreatment modality030220 oncology & carcinogenesisQuality of LifeDisease characteristicsDermatologic AgentsbusinessExpert Opinion on Drug Safety
researchProduct

Levocetirizine for the treatment of itch in psoriasis patients: An open-label pilot study in a real-world setting.

2019

Itch is the most bothersome symptom in psoriasis, often leading to impaired quality of life. Treatment of psoriasis-induced itch is frequently unsatisfactory as the various therapies employed have a delayed onset of effect. Histamine-1 receptor (H1) antihistamines are not recommended in treatment guidelines as histamine is not considered a key mediator in psoriasis. However, patients using H1 antihistamines frequently report benefits in questionnaire-based studies. To address these contradictions, we examined the short-term effects of levocetirizine, a nonsedating H1 antihistamine, on psoriasis-related itch and itch-related quality of life. In this pilot study, patients with psoriasis-relat…

AdultMalemedicine.medical_specialtyHistamine H1 Antagonists Non-SedatingTime FactorsPilot ProjectsDermatologyLevocetirizine030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of lifeimmune system diseasesPsoriasisparasitic diseasesotorhinolaryngologic diseasesMedicineEffective treatmentHumansPsoriasisskin and connective tissue diseasesH1 antihistamineDose-Response Relationship Drugbusiness.industryPruritusDelayed onsetGeneral MedicineMiddle Agedmedicine.diseaseDermatologyeye diseasesCetirizineTreatment Outcome030220 oncology & carcinogenesisConcomitantQuality of LifeFemaleOpen labelbusinessmedicine.drugDermatologic therapyREFERENCES
researchProduct

The relationship between PASI and DLQI with itch, stress, and depression: Do we need additional decision‐making tools in psoriasis?

2019

medicine.medical_specialtyDepressionbusiness.industryMEDLINEDermatologyGeneral Medicinemedicine.diseaseSeverity of Illness IndexQuality of lifePsoriasisSeverity of illnessQuality of LifemedicineHumansPsoriasisPsychiatrybusinessDepression (differential diagnoses)Dermatologic Therapy
researchProduct

Review of biologics in allergic contact dermatitis

2020

The resistant and recalcitrant nature of severe allergic contact dermatitis (ACD) makes its management challenging. With advances in the understanding of the cellular and molecular pathogenesis of ACD, newer therapeutic targets are becoming apparent. In particular, the use of biologics has gained momentum, given the specificity of their action. This article aims to review the presently available data on the use of biologics in ACD. English-language-based literature available on the use of biological therapy was thoroughly probed in the following databases as on October 14, 2019: PubMed, Google Scholar, The Cochrane library, Embase, Scopus, and EBSCO. The following keywords were used: "conta…

medicine.medical_specialtyDermatologyOmalizumabEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineUstekinumabmedicineAdalimumabHumansImmunology and Allergy030212 general & internal medicineAllergic contact dermatitisBiological Productsbusiness.industryPatch Testsmedicine.diseaseDermatologyDupilumabInfliximabTreatment OutcomeDermatitis Allergic ContactSecukinumabbusinessmedicine.drugContact Dermatitis
researchProduct

The short‐term effect of levocetirizine on quality of life, stress, and depression in itchy psoriasis patients

2019

AdultHistamine H1 Antagonists Non-Sedatingmedicine.medical_specialtyMEDLINEDermatologyLevocetirizineQuality of life (healthcare)Surveys and QuestionnairesInternal medicinePsoriasisHumansPsoriasisMedicineTerm effectDepression (differential diagnoses)Depressionbusiness.industryPruritusGeneral MedicineMiddle AgedHistamine H1 Antagonistsmedicine.diseaseCetirizineQuality of LifebusinessStress Psychologicalmedicine.drugDermatologic Therapy
researchProduct

Pain reduction by dehydrated human amnion/chorion membrane allograft in nondiabetic leg ulcers might be an early indicator of good response: A case s…

2020

Dehydrated human amnion/chorion membrane allograft (dHACM) derived from placenta is increasingly used for skin and soft tissue repair in several medical specialties. Promising effects of dHACM were also reported in chronic venous and diabetic leg ulcers. However, dHACM is cost-intensive and its effect on chronic leg ulcers of other etiologies and pain reduction is unknown. Clinical predictors of a favorable response to dHACM during the early treatment period could help to limit unnecessary costs. In our case series with six patients suffering from chronic lower leg ulcers of various etiology, the effect of dHACM once per week on reduction of pain and wound size during a 5-week period was ex…

Chronic woundmedicine.medical_specialtyPainDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineMedicineHumansAmnionCalciphylaxisAmnionbusiness.industryLeg UlcerDehydrated Human Amnion/Chorion MembraneReactive angioendotheliomatosisGeneral MedicineChorionmedicine.diseaseAllograftsSurgerymedicine.anatomical_structurePain reduction030220 oncology & carcinogenesisEtiologymedicine.symptombusinessWound healingDermatologic therapyREFERENCES
researchProduct